L&T Technology Services Limited (LTTS), a leading provider of engineering services, has joined forces with NVIDIA to drive innovation in the field of medical imaging. Their collaboration aims to develop groundbreaking software-defined architectures for medical devices, with a particular focus on endoscopy. By leveraging advanced technologies and artificial intelligence (AI), this partnership seeks to enhance image quality, scalability, and accessibility in the industry.
The newly developed software-defined architecture provides a scalable platform that supports multiple applications, enabling real-time decision-making for medical professionals. It incorporates an image processing pipeline that offers a range of enhancements, including noise reduction, contrast enhancement, texture and color enhancement, and speckle correction. The architecture also integrates advanced AI and machine learning models for the detection, identification, and classification of polyps often encountered during colonoscopies. The result is improved visualization and diagnosis, empowering medical practitioners with enhanced tools for patient care.
Central to this groundbreaking solution are NVIDIA’s cutting-edge Holoscan and IGX Orin platforms. These platforms offer ultra-low latency in data transfer, superior image processing capabilities, and the ability to support multiple AI-enabled applications. By combining LTTS’s expertise in medical device development with NVIDIA’s full-stack edge AI computing platform, the collaboration provides an end-to-end solution for developing AI-powered, software-defined medical devices in real-time. This represents a significant milestone in medical imaging, offering a new level of capabilities and possibilities for healthcare practitioners.
Shanker Trivedi, Senior Vice President of Enterprise Business at NVIDIA, expressed enthusiasm about this collaboration, emphasizing the value it brings to the medical technology industry. The partnership between LTTS and NVIDIA combines their respective strengths in medical device development and edge AI computing, facilitating the accelerated development of AI-enabled, software-defined medical devices and real-time AI applications.
Amit Chadha, CEO and Managing Director of L&T Technology Services, highlighted the vital role of this collaboration in pushing the boundaries of medical imaging capabilities. Chadha explained that by leveraging NVIDIA’s Holoscan and IGX Orin platforms, the development of AI-powered medical imaging solutions can be accelerated, resulting in improved image quality, efficient clinical decision-making support, and ultimately better patient outcomes.
The collaboration between LTTS and NVIDIA signifies a significant step forward in the field of medical imaging, offering the potential to transform healthcare practices. With the integration of cutting-edge technology, medical professionals will have advanced tools at their disposal to enhance diagnoses and ultimately improve patient care.